COMT Val(158)Met and BDNF C(270)T polymorphisms in schizophrenia: a case-control study.

Schizophr Res 2005 Feb;73(1):27-30

Department of Psychiatry, University of Naples SUN, Largo Madonna delle Grazie 1, 80138 Naples, Italy.

In a multicenter study involving 217 subjects of European ancestry [106 patients with schizophrenia and 111 healthy subjects], we tested the hypothesis that the catechol-O-methyl transferase (COMT) Val(158)Met and/or the brain-derived neurotrophic factor (BDNF) C(270)T gene polymorphisms are associated with schizophrenia. The COMT and BDNF genotype and their allele distribution did not differ between patients with schizophrenia and healthy comparison subjects. These results do not support the hypothesis that the COMT Val(158)Met or BDNF C(270)T gene polymorphisms are associated with liability to schizophrenia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2004.06.017DOI Listing
February 2005
7 Reads

Publication Analysis

Top Keywords

bdnf c270t
12
comt val158met
12
gene polymorphisms
8
c270t gene
8
polymorphisms associated
8
val158met bdnf
8
patients schizophrenia
8
schizophrenia
5
comt
4
hypothesis catechol-o-methyl
4
catechol-o-methyl transferase
4
tested hypothesis
4
schizophrenia healthy
4
healthy subjects]
4
transferase comt
4
111 healthy
4
genotype allele
4
healthy comparison
4
subjects] tested
4
brain-derived neurotrophic
4

Similar Publications